Shunxin
Lin obtained his B.S./M.S. (2012) combined degree in pharmaceutical
sciences from University at Buffalo, SUNY. Shunxin joined the Ph.D
program at Buffalo in 2012. His research project focuses on developing
anti-bacterium (Treponema denticola and Acinetobacter Baumannii)
antibodies and developing PBPK models for predicting antibody
disposition.
Balthasar Laboratory,
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, The
State University of New York